Skip to content

Intervention study of assessing platelet aggregation about patients receiving Ticagrelor with old myocardial infarction

Intervention study of assessing platelet aggregation about patients receiving Ticagrelor with old myocardial infarction - Assessment of platelet aggregation about OMI patients receiving Ticagrelor

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028077
Enrollment
35
Registered
2017-07-05
Start date
2017-12-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Old myocardial infarction

Interventions

administration of Ticagrelor

Sponsors

Chiba university hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Old myocardial infarction patients who had emergent PCI 3 months ago.

Exclusion criteria

Exclusion criteria: Patients with contraindications against Tiacgrelor

Design outcomes

Primary

MeasureTime frame
To compare the average value of P2Y12 reaction units (PRU) after administration of Ticagrelor for 14 days with Prasugrel

Countries

Japan

Contacts

Public ContactKazuya Tateishi

Chiba university hospital Cardiology

kazuyatateishi0926@gmail.com043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026